PubMed:21470983
Annnotations
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 94-108 | FMAID:62871 | denotes | immunoglobulin |
| _T2 | 94-108 | FMAID:167177 | denotes | immunoglobulin |
| _T3 | 94-110 | FMAID:62872 | denotes | immunoglobulin G |
| _T4 | 94-110 | FMAID:167178 | denotes | immunoglobulin G |
| _T5 | 94-110 | FMAID:62875 | denotes | immunoglobulin G |
| _T6 | 94-110 | FMAID:167181 | denotes | immunoglobulin G |
| _T7 | 94-110 | FMAID:62876 | denotes | immunoglobulin G |
| _T8 | 94-110 | FMAID:167187 | denotes | immunoglobulin G |
| _T9 | 94-110 | FMAID:167183 | denotes | immunoglobulin G |
| _T10 | 94-110 | FMAID:62874 | denotes | immunoglobulin G |
| _T11 | 94-110 | FMAID:167185 | denotes | immunoglobulin G |
| _T12 | 94-110 | FMAID:62873 | denotes | immunoglobulin G |
| _T13 | 112-115 | FMAID:167179 | denotes | IgG |
| _T14 | 120-130 | FMAID:82750 | denotes | asparigine |
| _T15 | 120-130 | FMAID:196739 | denotes | asparigine |
| _T16 | 168-176 | FMAID:167180 | denotes | antibody |
| _T17 | 312-316 | FMAID:167179 | denotes | IgGs |
| _T18 | 499-503 | FMAID:167179 | denotes | IgGs |
| _T19 | 505-515 | FMAID:167180 | denotes | antibodies |
| _T20 | 766-774 | FMAID:167180 | denotes | antibody |
| _T21 | 1406-1414 | FMAID:167180 | denotes | antibody |
| _T22 | 1504-1512 | FMAID:167180 | denotes | antibody |
| _T23 | 1569-1577 | FMAID:167180 | denotes | antibody |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 371-373 | http://www.uniprot.org/uniprot/P02760 | denotes | HC |
| T2 | 415-417 | http://www.uniprot.org/uniprot/P02760 | denotes | HC |
| T3 | 579-581 | http://www.uniprot.org/uniprot/P02760 | denotes | HC |
| T4 | 371-373 | http://www.uniprot.org/uniprot/P20061 | denotes | HC |
| T5 | 415-417 | http://www.uniprot.org/uniprot/P20061 | denotes | HC |
| T6 | 579-581 | http://www.uniprot.org/uniprot/P20061 | denotes | HC |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1019-1026 | http://purl.bioontology.org/ontology/NCBITAXON/68933 | denotes | thermal |
| T2 | 1216-1225 | http://purl.bioontology.org/ontology/STY/T192 | denotes | receptors |
| T3 | 1610-1629 | http://purl.bioontology.org/ontology/STY/T039 | denotes | biological function |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 60-73 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T2 | 77-90 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T3 | 273-286 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T4 | 534-547 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T5 | 693-706 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T6 | 863-876 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T7 | 339-351 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T8 | 375-387 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T9 | 418-430 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T10 | 486-498 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T11 | 585-597 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T12 | 810-822 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T13 | 977-989 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T14 | 1129-1141 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylated |
| T15 | 191-211 | http://purl.obolibrary.org/obo/GO_0019724 | denotes | immune cell-mediated |
| T16 | 191-211 | http://purl.obolibrary.org/obo/GO_0002443 | denotes | immune cell-mediated |
| T17 | 191-211 | http://purl.obolibrary.org/obo/GO_0002456 | denotes | immune cell-mediated |
| T18 | 191-211 | http://purl.obolibrary.org/obo/GO_0001909 | denotes | immune cell-mediated |
| T19 | 191-211 | http://purl.obolibrary.org/obo/GO_0002228 | denotes | immune cell-mediated |
| T20 | 191-211 | http://purl.obolibrary.org/obo/GO_0002449 | denotes | immune cell-mediated |
| T21 | 1444-1448 | http://purl.obolibrary.org/obo/GO_0001788 | denotes | ADCC |
| T22 | 1454-1458 | http://purl.obolibrary.org/obo/GO_0001788 | denotes | ADCC |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 94-108 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | immunoglobulin |
| T2 | 168-176 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T3 | 766-774 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T4 | 1406-1414 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T5 | 1504-1512 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
| T6 | 505-515 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T7 | 906-921 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antigen binding |
| T8 | 914-921 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T9 | 963-970 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T10 | 1093-1100 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T11 | 1177-1184 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T12 | 1345-1352 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T13 | 914-921 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T14 | 963-970 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T15 | 1093-1100 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T16 | 1177-1184 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T17 | 1345-1352 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T18 | 914-921 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T19 | 963-970 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T20 | 1093-1100 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T21 | 1177-1184 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T22 | 1345-1352 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T23 | 914-921 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T24 | 963-970 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T25 | 1093-1100 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T26 | 1177-1184 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T27 | 1345-1352 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T28 | 951-970 | http://purl.obolibrary.org/obo/GO_0034987 | denotes | Fc receptor binding |
| T29 | 954-970 | http://purl.obolibrary.org/obo/GO_0005102 | denotes | receptor binding |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 34-38 | http://purl.obolibrary.org/obo/GO_0071735 | denotes | IgG1 |
| T2 | 761-765 | http://purl.obolibrary.org/obo/GO_0071735 | denotes | IgG1 |
| T3 | 198-202 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T4 | 1425-1429 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T5 | 499-515 | http://purl.obolibrary.org/obo/GO_0071736 | denotes | IgGs, antibodies |
| T6 | 761-774 | http://purl.obolibrary.org/obo/GO_0071736 | denotes | IgG1 antibody |
| T7 | 923-926 | http://purl.obolibrary.org/obo/GO_0005731 | denotes | nor |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21470983_1_0 | 94-110 | expanded | denotes | immunoglobulin G |
| SS2_21470983_1_0 | 112-115 | abbr | denotes | IgG |
| SS1_21470983_2_0 | 358-369 | expanded | denotes | heavy chain |
| SS2_21470983_2_0 | 371-373 | abbr | denotes | HC |
| SS1_21470983_7_0 | 1207-1225 | expanded | denotes | Fc gamma receptors |
| SS2_21470983_7_0 | 1227-1232 | abbr | denotes | FcγRs |
| SS1_21470983_8_0 | 1406-1442 | expanded | denotes | antibody-dependent cell cytotoxicity |
| SS2_21470983_8_0 | 1444-1448 | abbr | denotes | ADCC |
| AE1_21470983_1_0 | SS1_21470983_1_0 | SS2_21470983_1_0 | abbreviatedTo | immunoglobulin G,IgG |
| AE1_21470983_2_0 | SS1_21470983_2_0 | SS2_21470983_2_0 | abbreviatedTo | heavy chain,HC |
| AE1_21470983_7_0 | SS1_21470983_7_0 | SS2_21470983_7_0 | abbreviatedTo | Fc gamma receptors,FcγRs |
| AE1_21470983_8_0 | SS1_21470983_8_0 | SS2_21470983_8_0 | abbreviatedTo | antibody-dependent cell cytotoxicity,ADCC |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-74 | Sentence | denotes | Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. |
| TextSentencer_T2 | 75-233 | Sentence | denotes | N-glycosylation of immunoglobulin G (IgG) at asparigine residue 297 plays a critical role in antibody stability and immune cell-mediated Fc effector function. |
| TextSentencer_T3 | 234-432 | Sentence | denotes | Current understanding pertaining to Fc glycosylation is based on studies with IgGs that are either fully glycosylated [both heavy chain (HC) glycosylated] or aglycosylated (neither HC glycosylated). |
| TextSentencer_T4 | 433-629 | Sentence | denotes | No study has been reported on the properties of hemi-glycosylated IgGs, antibodies with asymmetrical glycosylation in the Fc region such that one HC is glycosylated and the other is aglycosylated. |
| TextSentencer_T5 | 630-835 | Sentence | denotes | We report here for the first time a detailed study of how hemi-glycosylation affects the stability and functional activities of an IgG1 antibody, mAb-X, in comparison to its fully glycosylated counterpart. |
| TextSentencer_T6 | 836-971 | Sentence | denotes | Our results show that hemi-glycosylation does not impact Fab-mediated antigen binding, nor does it impact neonatal Fc receptor binding. |
| TextSentencer_T7 | 972-1101 | Sentence | denotes | Hemi-glycosylated mAb-X has slightly decreased thermal stability in the CH2 domain and a moderate decrease (∼20%) in C1q binding. |
| TextSentencer_T8 | 1102-1330 | Sentence | denotes | More importantly, the hemi-glycosylated form shows significantly decreased binding affinities toward all Fc gamma receptors (FcγRs) including the high-affinity FcγRI, and the low-affinity FcγRIIA, FcγRIIB, FcγRIIIA and FcγRIIIB. |
| TextSentencer_T9 | 1331-1450 | Sentence | denotes | The decreased binding affinities to FcγRs result in a 3.5-fold decrease in antibody-dependent cell cytotoxicity (ADCC). |
| TextSentencer_T10 | 1451-1645 | Sentence | denotes | As ADCC often plays an important role in therapeutic antibody efficacy, glycosylation status will not only affect the antibody quality but also may impact the biological function of the product. |
| T1 | 0-74 | Sentence | denotes | Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. |
| T2 | 75-233 | Sentence | denotes | N-glycosylation of immunoglobulin G (IgG) at asparigine residue 297 plays a critical role in antibody stability and immune cell-mediated Fc effector function. |
| T3 | 234-432 | Sentence | denotes | Current understanding pertaining to Fc glycosylation is based on studies with IgGs that are either fully glycosylated [both heavy chain (HC) glycosylated] or aglycosylated (neither HC glycosylated). |
| T4 | 433-629 | Sentence | denotes | No study has been reported on the properties of hemi-glycosylated IgGs, antibodies with asymmetrical glycosylation in the Fc region such that one HC is glycosylated and the other is aglycosylated. |
| T5 | 630-835 | Sentence | denotes | We report here for the first time a detailed study of how hemi-glycosylation affects the stability and functional activities of an IgG1 antibody, mAb-X, in comparison to its fully glycosylated counterpart. |
| T6 | 836-971 | Sentence | denotes | Our results show that hemi-glycosylation does not impact Fab-mediated antigen binding, nor does it impact neonatal Fc receptor binding. |
| T7 | 972-1101 | Sentence | denotes | Hemi-glycosylated mAb-X has slightly decreased thermal stability in the CH2 domain and a moderate decrease (∼20%) in C1q binding. |
| T8 | 1102-1330 | Sentence | denotes | More importantly, the hemi-glycosylated form shows significantly decreased binding affinities toward all Fc gamma receptors (FcγRs) including the high-affinity FcγRI, and the low-affinity FcγRIIA, FcγRIIB, FcγRIIIA and FcγRIIIB. |
| T9 | 1331-1450 | Sentence | denotes | The decreased binding affinities to FcγRs result in a 3.5-fold decrease in antibody-dependent cell cytotoxicity (ADCC). |
| T10 | 1451-1645 | Sentence | denotes | As ADCC often plays an important role in therapeutic antibody efficacy, glycosylation status will not only affect the antibody quality but also may impact the biological function of the product. |
| T1 | 0-74 | Sentence | denotes | Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. |
| T2 | 75-233 | Sentence | denotes | N-glycosylation of immunoglobulin G (IgG) at asparigine residue 297 plays a critical role in antibody stability and immune cell-mediated Fc effector function. |
| T3 | 234-432 | Sentence | denotes | Current understanding pertaining to Fc glycosylation is based on studies with IgGs that are either fully glycosylated [both heavy chain (HC) glycosylated] or aglycosylated (neither HC glycosylated). |
| T4 | 433-629 | Sentence | denotes | No study has been reported on the properties of hemi-glycosylated IgGs, antibodies with asymmetrical glycosylation in the Fc region such that one HC is glycosylated and the other is aglycosylated. |
| T5 | 630-835 | Sentence | denotes | We report here for the first time a detailed study of how hemi-glycosylation affects the stability and functional activities of an IgG1 antibody, mAb-X, in comparison to its fully glycosylated counterpart. |
| T6 | 836-971 | Sentence | denotes | Our results show that hemi-glycosylation does not impact Fab-mediated antigen binding, nor does it impact neonatal Fc receptor binding. |
| T7 | 972-1101 | Sentence | denotes | Hemi-glycosylated mAb-X has slightly decreased thermal stability in the CH2 domain and a moderate decrease (∼20%) in C1q binding. |
| T8 | 1102-1330 | Sentence | denotes | More importantly, the hemi-glycosylated form shows significantly decreased binding affinities toward all Fc gamma receptors (FcγRs) including the high-affinity FcγRI, and the low-affinity FcγRIIA, FcγRIIB, FcγRIIIA and FcγRIIIB. |
| T9 | 1331-1450 | Sentence | denotes | The decreased binding affinities to FcγRs result in a 3.5-fold decrease in antibody-dependent cell cytotoxicity (ADCC). |
| T10 | 1451-1645 | Sentence | denotes | As ADCC often plays an important role in therapeutic antibody efficacy, glycosylation status will not only affect the antibody quality but also may impact the biological function of the product. |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G41652MJ" | denotes | all |
| GlycanIUPAC_T2 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G20761YC" | denotes | all |
| GlycanIUPAC_T3 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G19807HM" | denotes | all |
| GlycanIUPAC_T4 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G20351TE" | denotes | all |
| GlycanIUPAC_T5 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G71957MR" | denotes | all |
| GlycanIUPAC_T6 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G59040AE" | denotes | all |
| GlycanIUPAC_T7 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G14987PW" | denotes | all |
| GlycanIUPAC_T8 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G95064PC" | denotes | all |
| GlycanIUPAC_T9 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G39143AQ" | denotes | all |
| GlycanIUPAC_T10 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G65149OO" | denotes | all |
| GlycanIUPAC_T11 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G02766SY" | denotes | all |
| GlycanIUPAC_T12 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G26019KJ" | denotes | all |
| GlycanIUPAC_T13 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G36429CZ" | denotes | all |
| GlycanIUPAC_T14 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G89633TP" | denotes | all |
| GlycanIUPAC_T15 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G28494FO" | denotes | all |
| GlycanIUPAC_T16 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G06219CP" | denotes | all |
| GlycanIUPAC_T17 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G44237SM" | denotes | all |
| GlycanIUPAC_T18 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G57948RL" | denotes | all |
| GlycanIUPAC_T19 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G64016DN" | denotes | all |
| GlycanIUPAC_T20 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G14536PC" | denotes | all |
| GlycanIUPAC_T21 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G14356FW" | denotes | all |
| GlycanIUPAC_T22 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G34565UO" | denotes | all |
| GlycanIUPAC_T23 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G67124MW" | denotes | all |
| GlycanIUPAC_T24 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G71457ZU" | denotes | all |
| GlycanIUPAC_T25 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G55228VZ" | denotes | all |
| GlycanIUPAC_T26 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G31034MJ" | denotes | all |
| GlycanIUPAC_T27 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G25776IP" | denotes | all |
| GlycanIUPAC_T28 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G64442BV" | denotes | all |
| GlycanIUPAC_T29 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G57018LE" | denotes | all |
| GlycanIUPAC_T30 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G61761GX" | denotes | all |
| GlycanIUPAC_T31 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G76318UX" | denotes | all |
| GlycanIUPAC_T32 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G61906ER" | denotes | all |
| GlycanIUPAC_T33 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G68723GR" | denotes | all |
| GlycanIUPAC_T34 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G19540LE" | denotes | all |
| GlycanIUPAC_T35 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G74944PO" | denotes | all |
| GlycanIUPAC_T36 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G89489ZJ" | denotes | all |
| GlycanIUPAC_T37 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G04434YU" | denotes | all |
| GlycanIUPAC_T38 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G21450PB" | denotes | all |
| GlycanIUPAC_T39 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G93629QY" | denotes | all |
| GlycanIUPAC_T40 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G02603TR" | denotes | all |
| GlycanIUPAC_T41 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G40280JP" | denotes | all |
| GlycanIUPAC_T42 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G95259IC" | denotes | all |
| GlycanIUPAC_T43 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G26900FE" | denotes | all |
| GlycanIUPAC_T44 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G21346KK" | denotes | all |
| GlycanIUPAC_T45 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G62509FF" | denotes | all |
| GlycanIUPAC_T46 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G83932AK" | denotes | all |
| GlycanIUPAC_T47 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G96978IB" | denotes | all |
| GlycanIUPAC_T48 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G34275DN" | denotes | all |
| GlycanIUPAC_T49 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G07071JF" | denotes | all |
| GlycanIUPAC_T50 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G80639QD" | denotes | all |
| GlycanIUPAC_T51 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G99460PJ" | denotes | all |
| GlycanIUPAC_T52 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G22024BZ" | denotes | all |
| GlycanIUPAC_T53 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G74097ZY" | denotes | all |
| GlycanIUPAC_T54 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G84439YP" | denotes | all |
| GlycanIUPAC_T55 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G52207WQ" | denotes | all |
| GlycanIUPAC_T56 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G90695MS" | denotes | all |
| GlycanIUPAC_T57 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G50398QX" | denotes | all |
| GlycanIUPAC_T58 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G12166ZT" | denotes | all |
| GlycanIUPAC_T59 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G48368BR" | denotes | all |
| GlycanIUPAC_T60 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G57407RW" | denotes | all |
| GlycanIUPAC_T61 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G00386TY" | denotes | all |
| GlycanIUPAC_T62 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G18723JK" | denotes | all |
| GlycanIUPAC_T63 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G93757OR" | denotes | all |
| GlycanIUPAC_T64 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G29006SI" | denotes | all |
| GlycanIUPAC_T65 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G03099OQ" | denotes | all |
| GlycanIUPAC_T66 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G53739OW" | denotes | all |
| GlycanIUPAC_T67 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G70440ZO" | denotes | all |
| GlycanIUPAC_T68 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G29951RR" | denotes | all |
| GlycanIUPAC_T69 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G58402TI" | denotes | all |
| GlycanIUPAC_T70 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G39875TP" | denotes | all |
| GlycanIUPAC_T71 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G83439QV" | denotes | all |
| GlycanIUPAC_T72 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G41762RC" | denotes | all |
| GlycanIUPAC_T73 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G91604UI" | denotes | all |
| GlycanIUPAC_T74 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G88447WE" | denotes | all |
| GlycanIUPAC_T75 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G93634BS" | denotes | all |
| GlycanIUPAC_T76 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G02587BH" | denotes | all |
| GlycanIUPAC_T77 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G43511MX" | denotes | all |
| GlycanIUPAC_T78 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G64958DH" | denotes | all |
| GlycanIUPAC_T79 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G30384TR" | denotes | all |
| GlycanIUPAC_T80 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G15624EX" | denotes | all |
| GlycanIUPAC_T81 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G22706ST" | denotes | all |
| GlycanIUPAC_T82 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G57408PI" | denotes | all |
| GlycanIUPAC_T83 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G86403XX" | denotes | all |
| GlycanIUPAC_T84 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G78043YB" | denotes | all |
| GlycanIUPAC_T85 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G18952JK" | denotes | all |
| GlycanIUPAC_T86 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G49020ND" | denotes | all |
| GlycanIUPAC_T87 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G63590YW" | denotes | all |
| GlycanIUPAC_T88 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G22793KS" | denotes | all |
| GlycanIUPAC_T89 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G64134SS" | denotes | all |
| GlycanIUPAC_T90 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G17338HY" | denotes | all |
| GlycanIUPAC_T91 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G99745XF" | denotes | all |
| GlycanIUPAC_T92 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G27782HN" | denotes | all |
| GlycanIUPAC_T93 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G57496DC" | denotes | all |
| GlycanIUPAC_T94 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G93169WB" | denotes | all |
| GlycanIUPAC_T95 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G05518TD" | denotes | all |
| GlycanIUPAC_T96 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G62603DN" | denotes | all |
| GlycanIUPAC_T97 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G59574FS" | denotes | all |
| GlycanIUPAC_T98 | 1203-1206 | "http://rdf.glycoinfo.org/glycan/G47567WC" | denotes | all |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 659-665 | OrganismTaxon | denotes | time a | 269051 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 191-202 | Body_part | denotes | immune cell | http://purl.obolibrary.org/obo/CL_0000738 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 191-202 | Cell | denotes | immune cell | http://purl.obolibrary.org/obo/CL:0000738 |